DNB Carnegie Downgrades Swedish Orphan Biovitrum to Hold, Lifts PT

MT Newswires · 2d ago
08:30 AM EDT, 07/17/2026 (MT Newswires) -- DNB Carnegie on Friday downgraded biopharmaceutical company Swedish Orphan Biovitrum (SOBI.ST) to hold from buy and increased its price target to 475 kronor from 473 kronor. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)